Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72808 record(s)

Req # A-2023-000632

Adverse Drug Reaction (ADR) for CUVITRU. Report number: 001039475. ADRs for GAMMAGARD LIQUID. Report numbers: 001040660, 001039696, 001040672, 001039691, 001039699, 001040665. ADRs for IMMUNOGLOBULIN (HUMAN). Report numbers: E2B_06352393,…

Organization: Health Canada

115 page(s)
November 2023

Req # A-2023-000640

Adverse Drug Reactions (ADRs). Report numbers: 001037727, 001042563, E2B_06389094, E2B_06347544, E2B_06362584.

Organization: Health Canada

40 page(s)
November 2023

Req # A-2023-000658

Adverse Drug Reactions (ADRs). Report numbers: E2B_04619567, E2B_04582728, E2B_03722288, E2B_04110358, E2B_02891039, E2B_02541469, E2B_05378319, E2B_01294965, E2B_03863914, E2B_06191407.

Organization: Health Canada

552 page(s)
November 2023

Req # A-2023-000670

Adverse Drug Reactions (ADRs). Report numbers: E2B_06381530, E2B_06401817, E2B_03046349, 001039522, 001039514, E2B_06400028, E2B_06262041, E2B_06178431, 001020862, E2B_06388027.

Organization: Health Canada

462 page(s)
November 2023

Req # A-2023-000671

Adverse Drug Reactions (ADRs). Report numbers: E2B_02239177, E2B_02869593.

Organization: Health Canada

68 page(s)
November 2023

Req # A-2023-000693

Adverse Drug Reactions (ADRs) for PATIROMER. Report numbers: E2B_06435279, E2B_06441728. ADRs for TAVNEOS. Report numbers: E2B_06450187, E2B_06459323. ADRs for REXULTI. Report numbers: 001046754, E2B_06452812. ADRs for REXULTI AND ARIPIPRAZOLE.…

Organization: Health Canada

96 page(s)
November 2023

Req # A-2023-000699

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-105064-604.

Organization: Health Canada

4 page(s)
November 2023

Req # A-2023-000702

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-105279-785.

Organization: Health Canada

23 page(s)
November 2023

Req # A-2023-000703

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-105282-196.

Organization: Health Canada

22 page(s)
November 2023

Req # A-2023-000744

Adverse Drug Reaction (ADR). Report number: E2B_06009811.

Organization: Health Canada

20 page(s)
November 2023
Date modified: